Synovial Sarcoma Overview

Save information for later
Sign Up

Learn About Synovial Sarcoma

What is the definition of Synovial Sarcoma?
Synovial sarcoma is a rare and aggressive soft tissue sarcoma. However, as the tumor grows larger, affected people may notice a lump or swelling. In some cases, the tumor can limit range of motion or cause numbness and/or pain if it presses on nearby nerves. Although Synovial sarcoma does not have a clearly defined cause, genetic factors are believed to influence the development of this disease. Cells in these tumors are usually characterized by the presence of a translocation involving chromosomes X and 18. This translocation is specific to Synovial sarcoma and is often used to diagnose the condition.
What are the alternative names for Synovial Sarcoma?
  • Synovial sarcoma
  • Synovial cell sarcoma
  • Synovialosarcoma
Who are the top Synovial Sarcoma Local Doctors?
Dr. Mihaela Druta
Oncology | Hematology Oncology
Dr. Mihaela Druta
Oncology | Hematology Oncology

H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc

12902 Usf Magnolia Dr, 
Tampa, FL 
 (29.0 mi)
888-860-2778
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mihaela Druta is an Oncologist and a Hematologist Oncology provider in Tampa, Florida. Dr. Druta and is rated as an Elite provider by MediFind in the treatment of Synovial Sarcoma. Her top areas of expertise are Liposarcoma, Adult Soft Tissue Sarcoma, Synovial Sarcoma, and Myxoid Liposarcoma.

Dr. Nael E. Saad
Interventional Radiology | Radiology
Dr. Nael E. Saad
Interventional Radiology | Radiology

Sheridan Radiology Services Of Pinellas Inc

1501 Pasadena S Ave, 
South Pasadena, FL 
 (0.1 mi)
727-381-1000
Experience:
26+ years
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Nael Saad is an Interventional Radiologist and a Radiologist in South Pasadena, Florida. Dr. Saad has been practicing medicine for over 26 years and is rated as an Experienced provider by MediFind in the treatment of Synovial Sarcoma. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Liver Cancer, Fibrolamellar Carcinoma, Gastrostomy, and Bone Marrow Aspiration. Dr. Saad is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Anilkumar N. Raiker
Hematology Oncology | Hematology | Oncology
Dr. Anilkumar N. Raiker
Hematology Oncology | Hematology | Oncology

The Oncology Institute Fl, LLC

6499 38th Ave N, Suite G1, 
St Petersburg, FL 
 (3.8 mi)
727-381-3761
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Anilkumar Raiker is a Hematologist Oncology specialist and a Hematologist in St Petersburg, Florida. Dr. Raiker and is rated as an Experienced provider by MediFind in the treatment of Synovial Sarcoma. His top areas of expertise are Paget Disease of the Breast, Pleuropulmonary Blastoma, Breast Cancer, and Blood Clots. Dr. Raiker is currently accepting new patients.

View All Doctors
What are the latest Synovial Sarcoma Clinical Trials?
A Phase 1 Study of Peposertib (M3814) and Low-Dose Liposomal Doxorubicin (Doxil�) in Patients With Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas
A Phase 1 Study of Peposertib (M3814) and Low-Dose Liposomal Doxorubicin (Doxil�) in Patients With Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas
Enrollment Status: Recruiting
Publish Date: February 26, 2025
Intervention Type: Drug, Procedure
Study Phase: Phase 1

Summary: This phase I trial tests the safety, side effects, and best dose of combination therapy with liposomal doxorubicin and peposertib in treating patients with sarcoma that has spread from where it first started, to other places in the body (metastatic), or cannot be removed by surgery (unresectable) and for which no known cure is available (advanced). Doxorubicin is in a class of medications called a...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1/2 Open Label, Basket Study to Assess the Safety, Tolerability and Anti-Tumor Activity of Afamitresgene Autoleucel in Pediatric Subjects With MAGE-A4 Positive Tumors
A Phase 1/2 Open Label, Basket Study to Assess the Safety, Tolerability and Anti-Tumor Activity of Afamitresgene Autoleucel in Pediatric Subjects With MAGE-A4 Positive Tumors
Enrollment Status: Recruiting
Publish Date: February 26, 2025
Intervention Type: Genetic
Study Phase: Phase 1/Phase 2

Summary: This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-21 years of age with advanced cancers

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center